IGC Pharma raises ~$234k in registered direct offering of 780k shares at $0.30/share

IGC Pharma, Inc.

Issued 779,997 shares of common stock at $0.30 per share for gross proceeds of ~$234k.
Offering closed on or about January 5, 2026 under existing shelf registration statement.
Net proceeds to fund working capital, clinical development, R&D, and other business initiatives.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IGC Pharma, Inc. entered into 2025 Subscription Agreement with certain investors valued at approximately $234 thousand (effective 2026-01-05).

Action: entry
Agreement: equity purchase
Counterparty: certain investors
Value: approximately $234 thousand
Effective: 2026-01-05

Exact text from the filing

entered into a Subscription Agreement (the “2025 Subscription Agreement”) with certain investors named therein (collectively, the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a registered direct offering (the “Offering”), an aggregate of 779,997 shares of the Company’s common stock

View on SEC.gov

306 material agreements filed in the last 30 days. Browse all material agreements →

IGC Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001185185-26-000032

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.